The positivity rates for the apoA2-i Index and CA19-9 in PC patients were both 25%, respectively, with tumor sizes < 10 mm and 62.5% and 50.0%, respectively, in those with tumor sizes ranging from 10 to 20 mm. The gene discussed is APOA2; the disease is pachyonychia congenita.